氨基末端脑钠肽,NT-BNP
1)NT-BNP氨基末端脑钠肽
1.Objective: To compare the effects of insulin plus rosiglitazone with insulin plus metformin on serum N-terminal pro-brain natriuretic peptide(NT-BNP), adiponectin, leptin and C reaction protein(CRP) in type 2 diabetes mellitus.目的:比较胰岛素和罗格列酮联合治疗与胰岛素和二甲双胍联合治疗两种方案对2型糖尿病患者血清氨基末端脑钠肽(NT-BNP)、脂联素、瘦素及C反应蛋白(CRP)水平的影响。
英文短句/例句

1.Changes of Plasma Brain Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide of Sepsis Combined with Myocardial Injury in Newborns败血症并心肌损伤新生儿血浆脑钠肽及氨基末端脑钠肽水平变化的意义
2.Plasma N-Terminal Pro-Brain Natriuretic Peptide Levels Would Predict Perioperative Risk after Valvular Replacement Operation in Patients with Rheumatic Valve Disease氨基末端脑钠肽对风湿性瓣膜病患者围手术期风险性评估的意义
3.Comparison of clinical therapeutic effect and plasma NT-proBNP level in patients with acute cardiogenic pulmonary edema after different noninvasive mechanical ventilations血氨基末端脑钠肽前体(NT-proBNP)在通气治疗急性心源性肺水肿时的变化
4.Both cardiac troponin T and N-terminal pro-brain natriuretic peptide in children with heart failure联合检测氨基末端脑钠肽和肌钙蛋白T在儿童心力衰竭诊断中的意义
5.The Use of the Serum NT-proBNP Level in the Grading of Cardiac Function氨基末端B型利钠肽在心功能分级中的应用
6.Correlation between N-terminal Pro-brain Natriuretic Peptide and Cardiac Diastolic and Systolic Function脑型利尿钠肽前体氨基端肽与心脏舒缩功能的相关性研究
7.Investigation of the serum N-terminal pro-B-type natriuretic peptide reference intervals in apparently healthy individuals表面健康人群血清氨基末端B型钠尿肽原参考区间的调查
8.Value of Brain Natriuretic Petide and N-terminal Pro-brain Natriuretic Petide in Diagnosis of Diastolic Heart Failure脑钠肽和N-末端脑钠肽前体对舒张性心力衰竭的诊断价值
9.N-terminal Pro-B-type Natriuretic Peptide Kinetics During Dynamic Exercise in Patients with Stable COPDCOPD患者血浆氨基酸末端脑钠素前体在运动中的变化
10.Any of a group of enzymes that catalyze the hydrolysis of single amino acids from the end of a polypeptide chain.链肽端解酶能使肽链末端氨基酸形成的肽键水解的一组酶之一
11.Differential Diagnosis Value of Blood N-terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Dyspnea氨基末端B型尿钠肽前体对心源性与呼吸源性呼吸困难的鉴别诊断价值
12.Prognostic value of N-terminal pro-brain natriuretic peptide combined with soluble CD40L in acute coronary syndrome patients氨基端脑钠肽原与细胞分化抗原40配体联合预测急性冠脉综合征近期预后
13.Effect of bi-level positive airway pressure ventilation to N-terminal pro-brain natriuretic peptide in grade Ⅳ elderly heart failure patients双水平气道内正压通气对老年心功能Ⅳ级患者氨基端脑钠肽原的影响
14.The change of plasma N-terminal pro-brain natriuretic peptide levels in chronic obstructive pulmonary disease with heart failure合并心力衰竭对慢性阻塞性肺疾病患者血浆氨基酸末端脑钠素前体水平的影响
15.The Plasma NT-proBNP Level and Its Clinical Significance in Patients with Unstable Angina Pectoris;不稳定型心绞痛患者血浆N末端脑钠肽前体的变化及其临床意义
16.Research of N-terminal Pro-Brain Nitric Peptide for Congenital Heart Disease with Pulmonary Hypertension;N-末端脑利钠肽前体在先天性心脏病肺动脉高压中的应用研究
17.The Relationship between Echocardiogradhic Indices and Nt-Probnp in Patients with Cardiac Dysfunction;左心功能不全患者超声指数与N末端脑钠尿肽原的关系
18.The Comparison of NT-proBNP and ET Levels between Left and Right Ventricular DysfunctionN-末端脑利钠肽与内皮素在左、右心功能不全患者中水平的比较
相关短句/例句

N-terminal pro-brain natriuretic peptide氨基末端脑钠肽前体
1.Objective:To explore the plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) level of neonates with neonatal asphyxia and its clinical significance.目的:探讨窒息新生儿血浆氨基末端脑钠肽前体(NT-proBNP)水平及临床意义。
2.Serum N-terminal pro-brain natriuretic peptide levels on the prognosis of multiple organ dysfunction syndrome in the elderly;目的探讨老年多器官功能不全综合征(MODSE)患者血清氨基末端脑钠肽前体(NT-proBNP)水平变化及其临床意义。
3)human amino-terminal pro-brain natriuretic peptide人氨基末端脑钠肽
1.Objective To clone human amino-terminal pro-brain natriuretic peptide gene and obtain purified NT-proBNP for future proparation of antibody.目的:克隆人氨基末端脑钠肽(am ino-term inal pro-brain natriuretic peptide,NT-proBNP)基因,构建原核表达载体并纯化表达产物。
4)NT-proBNP氨基末端-脑钠肽前体
1.Diagnostic value of NT-proBNP in the differentiation of acute dyspnea;急诊呼吸困难患者氨基末端-脑钠肽前体的鉴别诊断价值
5)NT-proBNP氨基末端脑钠肽前体
1.To study the relationship between N-temrina probarin natriuretic peptide(NT-proBNP) level and cardiac functions in patients with congestive heart failure(CHF),the plasma level of NT-proBNP in 108 patients with CHF and 30 healthy controls were measured by electrochemiluminescence immunoassay(ECLIA) and left ventricular ejection fraction(LVEF) was measured by echocardiography.探讨充血性心力衰竭(CHF)患者血浆氨基末端脑钠肽前体(NT-proBNP)水平与心功能的关系。
2.Diastolic dysfunction is one of the important triggers for the release of brain natriuretic petide(BNP) and N-terminal pro-natriuretic petide(NT-proBNP) from the ventricular myocardium.舒张功能不全是触发心肌细胞释放脑钠肽(BNP)和氨基末端脑钠肽前体(NT-proBNP)的重要因素。
3.Methods HFEI in 116 patients with CHF(CHF group) and 24 normal controls(control group) were evaluated and compared with the levels of contemporaneous NT-ProBNP and the NYHA class, and the sensitivity and specificity of HFEI for CHF diagnosis were appraised.方法:前瞻性研究慢性心力衰竭患者116例(心衰组),正常者24例(对照组),所有入选者进行心衰超声指数的评分,并将该评分与同期血浆氨基末端脑钠肽前体(NT-ProBNP)水平及纽约心功能分级(NYHA)进行比较,同时评价其诊断慢性心力衰竭的敏感性与特异性。
6)NT-probrain natriuretic peptide氨基酸末端脑钠肽前体
延伸阅读

心房肽素,人心房利钠多肽药物名称:心房肽英文名:别名: 心房肽素,人心房利钠多肽;心钠素 ,心房肽适应症: 用于治疗高血压、肾性或肝性腹水、心力衰竭和原发性醛固酮增多症等,疗效显著。 用量用法: 静滴:每次0.2~0.4mg。 规格: 粉针剂:0.2mg。 类别:降血压药